Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.

Wada T, Konno A, Schurman SH, Garabedian EK, Anderson SM, Kirby M, Nelson DL, Candotti F.

J Clin Invest. 2003 May;111(9):1389-97.

2.

WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype.

Imai K, Nonoyama S, Ochs HD.

Curr Opin Allergy Clin Immunol. 2003 Dec;3(6):427-36. Review.

PMID:
14612666
3.

WASP and the phenotypic range associated with deficiency.

Notarangelo LD, Notarangelo LD, Ochs HD.

Curr Opin Allergy Clin Immunol. 2005 Dec;5(6):485-90. Review.

PMID:
16264326
4.

Wiskott-Aldrich syndrome.

Notarangelo LD, Miao CH, Ochs HD.

Curr Opin Hematol. 2008 Jan;15(1):30-6. Review.

PMID:
18043243
5.

Structure and function of the Wiskott-Aldrich syndrome protein.

Ochs HD, Notarangelo LD.

Curr Opin Hematol. 2005 Jul;12(4):284-91. Review.

PMID:
15928485
6.

[Molecular pathogenesis of Wiskott-Aldrich syndrome].

Sasahara Y, Tsuchiya S.

Nihon Rinsho Meneki Gakkai Kaishi. 2005 Jun;28(3):140-7. Review. Japanese.

7.

Wiskott-Aldrich syndrome protein and platelets.

Oda A, Ochs HD.

Immunol Rev. 2000 Dec;178:111-7. Review.

PMID:
11213795
8.

The Wiskott-Aldrich syndrome.

Ochs HD, Thrasher AJ.

J Allergy Clin Immunol. 2006 Apr;117(4):725-38; quiz 739. Review.

PMID:
16630926
9.

The Wiskott-Aldrich syndrome.

Ochs HD.

Semin Hematol. 1998 Oct;35(4):332-45. Review.

PMID:
9801262
10.
11.

Molecular biology of the Wiskott-Aldrich syndrome.

Rengan R, Ochs HD.

Rev Immunogenet. 2000;2(2):243-55. Review.

PMID:
11258421
12.

Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation.

Notarangelo LD, Ochs HD.

Curr Opin Immunol. 2003 Oct;15(5):585-91. Review.

PMID:
14499269
13.

Contributions of Wiskott-Aldrich syndrome family cytoskeletal regulatory adapters to immune regulation.

Zhang J, Dong B, Siminovitch KA.

Immunol Rev. 2009 Nov;232(1):175-94. doi: 10.1111/j.1600-065X.2009.00846.x. Review.

PMID:
19909364
14.

Recent advances in our understanding of Wiskott-Aldrich syndrome.

Sullivan KE.

Curr Opin Hematol. 1999 Jan;6(1):8-14. Review.

PMID:
9915548
15.

Understanding the molecular basis of Wiskott-Aldrich syndrome.

Abo A.

Cell Mol Life Sci. 1998 Oct;54(10):1145-53. Review.

PMID:
9817992
16.

Linking cellular activation to cytoskeletal reorganization: Wiskott-Aldrich syndrome as a model.

Stewart DM, Tian L, Nelson DL.

Curr Opin Allergy Clin Immunol. 2001 Dec;1(6):525-33. Review.

PMID:
11964736
17.

In vivo reversion to normal of inherited mutations in humans.

Hirschhorn R.

J Med Genet. 2003 Oct;40(10):721-8. Review.

18.

High incidence of lymphomas in a subgroup of Wiskott-Aldrich syndrome patients.

Shcherbina A, Candotti F, Rosen FS, Remold-O'Donnell E.

Br J Haematol. 2003 May;121(3):529-30. Review. No abstract available.

PMID:
12716381
19.

[Mutation of WASP in Wiskott-Aldrich syndrome and it's effect on megakaryopoiesis].

Nonoyama S.

Rinsho Ketsueki. 1998 Feb;39(2):133-4. Review. Japanese. No abstract available.

PMID:
9545824
20.

Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.

Boztug K, Dewey RA, Klein C.

Curr Opin Mol Ther. 2006 Oct;8(5):390-5. Review.

PMID:
17078381

Supplemental Content

Support Center